| Emerging targets in cancer management: role of the CXCL12/CXCR4 axis M Cojoc, C Peitzsch, F Trautmann, L Polishchuk, GD Telegeev, ... OncoTargets and therapy, 1347-1361, 2013 | 323 | 2013 |
| Aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells M Cojoc, C Peitzsch, I Kurth, F Trautmann, LA Kunz-Schughart, ... Cancer research 75 (7), 1482-1494, 2015 | 257 | 2015 |
| CXCR4 expression in prostate cancer progenitor cells A Dubrovska, J Elliott, RJ Salamone, GD Telegeev, AE Stakhovsky, ... PloS one 7 (2), e31226, 2012 | 174 | 2012 |
| An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells C Peitzsch, M Cojoc, L Hein, I Kurth, K Mäbert, F Trautmann, B Klink, ... Cancer research 76 (9), 2637-2651, 2016 | 75 | 2016 |
| Novel role of pleckstrin homology domain of the Bcr-Abl protein: Analysis of protein–protein and protein–lipid interactions D Miroshnychenko, A Dubrovska, S Maliuta, G Telegeev, P Aspenström Experimental cell research 316 (4), 530-542, 2010 | 41 | 2010 |
| Dextran-polyacrylamide as matrices for creation of anticancer nanocomposite G Telegeev, N Kutsevol, V Chumachenko, A Naumenko, P Telegeeva, ... International Journal of Polymer Science 2017, 2017 | 35 | 2017 |
| The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression A Tyutyunnykova, G Telegeev, A Dubrovska Journal of Cancer 8 (5), 716, 2017 | 27 | 2017 |
| Influence of BCR/ABL fusion proteins on the course of Ph leukemias. G Telegeev, A Dubrovska, M Dybkov, S Maliuta Acta Biochimica Polonica 51 (3), 845-849, 2004 | 19 | 2004 |
| Development of bioselective element of SPR spectrometer for monitoring of oligonucleotide interactions and comparison with thermodynamic calculations A Rachkov, Y Holodova, Y Ushenin, D Miroshnichenko, G Telegeev, ... Sensor Letters 7 (5), 957-961, 2009 | 17 | 2009 |
| Immunocytochemical study of Bcr and Bcr-Abl localization in K562 cells GD Telegeev, AN Dubrovska, VA Nadgorna, MV Dybkov, MP Zavelevich, ... Experimental Oncology, 2010 | 13 | 2010 |
| Colocalization of USP1 and РН domain of Bcr-Abl oncoprotein in terms of chronic myeloid leukemia cell rearrangements SV Antonenko, DS Gurianov, GD Telegeev Cytology and genetics 50, 352-356, 2016 | 11 | 2016 |
| Molecular-biology approaches to detection of Philadelphia chromosome in patients with leukemia GD Telegeev, MV Dybkov, MV Bozhko, NM Tretiak, SS Maliuta Biopolymers and Cell 12 (6), 63-68, 1996 | 10 | 1996 |
| Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling. DS Gurianov, SV Antonenko, GD Telegeev Biopolymers and cell, 26-33, 2016 | 9 | 2016 |
| Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells SV Antonenko, GD Telegeev Experimental oncology 42 (2), 109-114, 2020 | 8 | 2020 |
| Current state of human gene therapy: approved products and vectors AY Shchaslyvyi, SV Antonenko, MG Tesliuk, GD Telegeev Pharmaceuticals 16 (10), 1416, 2023 | 6 | 2023 |
| Interaction of Bcl-Abl oncoprotein with the Glg1 protein in K562 cells: its role in the pathogenesis of chronic myeloid leukemia SV Antonenko, IV Kravchuk, GD Telegeev Cytology and Genetics 54 (1), 48-54, 2020 | 6 | 2020 |
| Role of BCR/ABL in leukemogenesis GD Telegeev, AN Dubrovskaya, MV Dybkov Experimental oncology 21 (3-4), 182-94, 1999 | 6 | 1999 |
| Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E LP Shvachko, MP Zavelevich, DF Gluzman, GD Telegeev Experimental Oncology 42 (1), 31-34, 2020 | 5 | 2020 |
| Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells LP Shvachko, MP Zavelevich, DF Gluzman, IV Kravchuk, GD Telegeev Experimental oncology 40 (4), 328-331, 2018 | 5 | 2018 |
| Genetic diversity in populations of gentoo penguins (Pygoscelis papua) AS Dranitsina, GD Telegeev, SS Maliuta, FV Bezrukov Цитология и генетика, 2006 | 5 | 2006 |
